Performance-enhancing drugs, supplements and the athlete’s heart

The use of performance-enhancing drugs is an unfortunatereality of contemporary sport. It would be a mistake tobelieve that this is a phenomenon found only in elite sport.Athletes at all levels and young adults may be tempted toaccentuate performance or physique with prohibited drugsor products mark...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Andrew Pipe
Formato: article
Lenguaje:EN
Publicado: South African Heart Association 2017
Materias:
Acceso en línea:https://doaj.org/article/76307817b90e42b891c69cd5958a966f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:76307817b90e42b891c69cd5958a966f
record_format dspace
spelling oai:doaj.org-article:76307817b90e42b891c69cd5958a966f2021-11-29T12:23:27ZPerformance-enhancing drugs, supplements and the athlete’s heart10.24170/8-3-18951996-67412071-4602https://doaj.org/article/76307817b90e42b891c69cd5958a966f2017-04-01T00:00:00Zhttps://www.journals.ac.za/index.php/SAHJ/article/view/1895https://doaj.org/toc/1996-6741https://doaj.org/toc/2071-4602The use of performance-enhancing drugs is an unfortunatereality of contemporary sport. It would be a mistake tobelieve that this is a phenomenon found only in elite sport.Athletes at all levels and young adults may be tempted toaccentuate performance or physique with prohibited drugsor products marketed as supplements. No defined populationsof users ingesting known quantities of known substances are generally available for study. Many of these products have been associated with adverse health effects; cardiac structure and function are known to be affected by many of the products commonly abused. Changes to the lipoprotein profile, propensity for coagulation, coronary circulation, and ventricular function may accompany the use of many performance-enhancing compounds and methods. Anabolic steroids, other peptide hormones, stimulants, erythropoietin and blood doping, have all been associated with significant cardiovascular consequences. So-called nutritional supplements aggressively marketed to the athletically inclined, are available over the Internet and typically totally unregulated in the country of their origin. Clinicians should be aware of the problems that such drug use can engender, and be sensitive to the possibilities of such abuse in caring for athletes and young patients, particularly in those presenting with unusual or unanticipated cardiovascular signs and symptoms.Andrew PipeSouth African Heart Associationarticleperformance-enhancing drugsheart healthDiseases of the circulatory (Cardiovascular) systemRC666-701ENSA Heart Journal, Vol 8, Iss 3, Pp 164-170 (2017)
institution DOAJ
collection DOAJ
language EN
topic performance-enhancing drugs
heart health
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle performance-enhancing drugs
heart health
Diseases of the circulatory (Cardiovascular) system
RC666-701
Andrew Pipe
Performance-enhancing drugs, supplements and the athlete’s heart
description The use of performance-enhancing drugs is an unfortunatereality of contemporary sport. It would be a mistake tobelieve that this is a phenomenon found only in elite sport.Athletes at all levels and young adults may be tempted toaccentuate performance or physique with prohibited drugsor products marketed as supplements. No defined populationsof users ingesting known quantities of known substances are generally available for study. Many of these products have been associated with adverse health effects; cardiac structure and function are known to be affected by many of the products commonly abused. Changes to the lipoprotein profile, propensity for coagulation, coronary circulation, and ventricular function may accompany the use of many performance-enhancing compounds and methods. Anabolic steroids, other peptide hormones, stimulants, erythropoietin and blood doping, have all been associated with significant cardiovascular consequences. So-called nutritional supplements aggressively marketed to the athletically inclined, are available over the Internet and typically totally unregulated in the country of their origin. Clinicians should be aware of the problems that such drug use can engender, and be sensitive to the possibilities of such abuse in caring for athletes and young patients, particularly in those presenting with unusual or unanticipated cardiovascular signs and symptoms.
format article
author Andrew Pipe
author_facet Andrew Pipe
author_sort Andrew Pipe
title Performance-enhancing drugs, supplements and the athlete’s heart
title_short Performance-enhancing drugs, supplements and the athlete’s heart
title_full Performance-enhancing drugs, supplements and the athlete’s heart
title_fullStr Performance-enhancing drugs, supplements and the athlete’s heart
title_full_unstemmed Performance-enhancing drugs, supplements and the athlete’s heart
title_sort performance-enhancing drugs, supplements and the athlete’s heart
publisher South African Heart Association
publishDate 2017
url https://doaj.org/article/76307817b90e42b891c69cd5958a966f
work_keys_str_mv AT andrewpipe performanceenhancingdrugssupplementsandtheathletesheart
_version_ 1718407409030922240